Ba. Teicher et al., REDUCED OXYGENATION IN A RAT MAMMARY-CARCINOMA AFTER CHEMO-THERAPY ORRADIATION-THERAPY AND REOXYGENATION WITH PERFLUBRON EMULSION CARBOGENBREATHING/, Journal of cancer research and clinical oncology, 120(10), 1994, pp. 593-598
Rat 13672 mammary carcinoma tumors were grown subcutaneously in the hi
nd legs of female Fischer 344 rats to a volume of about 1 cm(3). Tumor
oxygenation was measured using an Eppendorf PO2 histograph. Tumor oxy
gen measurements were made under four conditions: (a) normal air breat
hing, (b) carbogen breathing, (c) after intravenous administration of
a perflubron emulsion (8 ml/kg) with air breathing and (d) after intra
venous administration of a perflubron emulsion (8 ml/kg) with carbogen
breathing. Tumor oxygenation was examined without treatment or 24 h a
nd 48 h after treatment with cyclophosphamide (300 mg/kg, i.p.) or cis
platin (8 mg/kg, i.p.] or after the fifth dose of a daily regimen of 3
-Gy irradiation (5x3 Gy). Under normal air-breathing conditions 49% of
the tumor had a PO2 less than or equal to 670 Pa (5 mm Hg). The degre
e of hypoxia in the tumors increased after each treatment such that 24
h after treatment 65%-85% of the oxygen readings were less than or eq
ual to 670 Pa and 48 h after treatment 60%-74% of the oxygen readings
were less than or equal to 670 Pa. Administration of the perflubron em
ulsion/carbogen atmosphere increased the oxygen content of the tumors
both without treatment and after each of the treatments. A knowledge o
f tumor oxygen content over the course of treatment and the ability to
increase tumor oxygen should allow for the development of more ration
al treatment combinations and better treatment outcomes.